INVO Fertility, Inc

IVF

Healthcare Medical Devices

INVO Fertility, Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 4.74% from fiscal 2024.

Revenue
+16.7%
EPS
+100.1%
Free cash flow
+35.1%
Total debt
−50.7%

Quarter to June 2026, against a year earlier

2.14 0.11 +5.42%
Market cap
$2.6M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
4/9
ROIC
−27.9%
Net debt / EBITDA
0.2×
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
4 4 4 3

+8 more TTM periods

ROE
(203.65%) 213.69% 387.43% 532.09%
ROA
(38.79%) (47.04%) (75.81%) (158.74%)
ROIC
(27.92%) (44.23%) (76.78%) (73.85%)
Return on Tangible Assets
807.97% 9,024.54% 349.81% 369.43%
Average Days of Receivables
12.49 12.56 11.59 14.41
Free Cash Flow per Share
(2.29) (3.29) (19.22) (90.11)
Free Cash Flow
(4.82) (5.39) (7.06) (7.77)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026